Sanofi to pump additional $625m into early stage biotech

Investments in neurodegeneration-focused startups set to continue as Sanofi Ventures gets significant cash infusion. Pharma giant Sanofi has revealed it is providing an additional $625 million to Sanofi Ventures, its corporate venture capital arm, with the funds earmarked for investments in early st…